The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVRP.L Share News (VRP)

  • There is currently no data for VRP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AZ Electronic Materials directors try to minimize damage

Wed, 10th Apr 2013 16:27

John Whybrow, the Chairman of AZ Electronic Materials, which on Tuesday tanked after it issued a warning on full year revenue, has shown his faith in the chemicals company by enlarging his shareholding. Whybrow acquired 40,000 shares at 254p each for a total trade value of £101,600, taking his stake in the company to 118,541 shares. Geoff Wild, the group's Chief Executive Officer, also made a significant purchase, buying 40,000 shares at 268p each. The £107,200 purchase takes his holding to 885,749.A number of other directors also gave the group their backing with purchases of various sizes. The company reported a 2.0% year-on-year decline in revenue to $19.9m for the three months to April 8th, following lower-than-expected sales in its IC Materials division. The company blamed weak performance and an unfavourable product mix in IC Materials, which includes products for use in integrated circuits and devices. Revenue in the division fell 7.0% year-on-year to $123.3m. As a result, the group's EBITDA (earnings before interest, tax, depreciation and amortisation) margin for the three month period was lower than normal, and will be for the year as a whole, it warned. Group revenue for the full year will be around the same levels as last year, the company added. Having lost around 30% of its value on Tuesday, the stock regained 15% the following morning, boosted in part by a rating upgrade from broker UBS. Top Director BuysCentamin (DI) (CEY) Director name: Mr Josef El-RaghyAmount purchased: 500,000 @ 47.80p Value: £239,000AZ Electronic Materials SA (DI) (AZEM) Director name: Mr Geoff WildAmount purchased: 40,000 @ 268.00p Value: £107,200AZ Electronic Materials SA (DI) (AZEM) Director name: Mr John WhybrowAmount purchased: 40,000 @ 254.00p Value: £101,600Synety Group (SNTY) Director name: Mr Simon CleaverAmount purchased: 40,000 @ 125.00p Value: £50,000AZ Electronic Materials SA (DI) (AZEM) Director name: Mr Andrew AllnerAmount purchased: 10,000 @ 255.00p Value: £25,500Verona Pharma (VRP) Director name: Mr Stuart BottomlyAmount purchased: 1,000,000 @ 2.35p Value: £23,500Mission Marketing Group (TMMG) Director name: Mr Chris GoodwinAmount purchased: 60,000 @ 34.00p Value: £20,400Cenkos Securities (CNKS) Director name: Mr Anthony HotsonAmount purchased: 20,000 @ 87.80p Value: £17,560Port Erin Biopharma Investments Ltd (PEBI) Director name: Mr James (Jim) MellonAmount purchased: 200,000 @ 7.50p Value: £15,000Synety Group (SNTY) Director name: Mr Simon CleaverAmount purchased: 10,000 @ 124.80p Value: £12,480Top Director SellsTelecity Group (TCY) Director name: Mr Brian McArthur MuscroftAmount sold: 98,789 @ 888.00p Value: £877,246Close Brothers Group (CBG) Director name: Mr Stephen R HodgesAmount sold: 76,383 @ 1,016.48p Value: £776,418Berendsen (BRSN) Director name: Mr Peter VentressAmount sold: 61,310 @ 782.80p Value: £479,935Spirax-Sarco Engineering (SPX) Director name: Mr Mark E. VernonAmount sold: 18,362 @ 2,608.78p Value: £479,024Amlin (AML) Director name: Mr Richard A HextallAmount sold: 72,533 @ 423.49p Value: £307,170Tarsus Group (TRS) Director name: Mr Douglas EmslieAmount sold: 86,449 @ 230.00p Value: £198,833National Express Group (NEX) Director name: Mr Dean K FinchAmount sold: 69,571 @ 195.89p Value: £136,283Tarsus Group (TRS) Director name: Mr Neville BuchAmount sold: 43,225 @ 230.00p Value: £99,418Tarsus Group (TRS) Director name: Mr Roger PellowAmount sold: 23,084 @ 230.00p Value: £53,093NR
More News
29 Oct 2020 19:09

IN BRIEF: Verona Pharma Says Third Quarter Loss Widens

IN BRIEF: Verona Pharma Says Third Quarter Loss Widens

Read more
22 Oct 2020 16:01

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
21 Sep 2020 14:12

IN BRIEF: Verona Pharma To Delist From AIM But Remain On Nasdaq

IN BRIEF: Verona Pharma To Delist From AIM But Remain On Nasdaq

Read more
14 Sep 2020 13:13

IN BRIEF: Cambridge Cognition Hires Diurnal CFO Bungay As Non-Exec

IN BRIEF: Cambridge Cognition Hires Diurnal CFO Bungay As Non-Exec

Read more
24 Aug 2020 11:09

Verona Pharma Says Study Shows Ensifentrine Improves Lung Function

Verona Pharma Says Study Shows Ensifentrine Improves Lung Function

Read more
19 Aug 2020 10:35

Verona Pharma Makes Progress In Phase Two Of Inhaler Clinical Trial

Verona Pharma Makes Progress In Phase Two Of Inhaler Clinical Trial

Read more
14 Aug 2020 12:12

LONDON MARKET MIDDAY: Travel Stocks Suffer As UK Extends Quarantine

LONDON MARKET MIDDAY: Travel Stocks Suffer As UK Extends Quarantine

Read more
14 Aug 2020 10:56

UK WINNERS & LOSERS SUMMARY: Airlines Hit As UK Quarantine List Grows

UK WINNERS & LOSERS SUMMARY: Airlines Hit As UK Quarantine List Grows

Read more
14 Aug 2020 09:22

Verona To Trial Ensifentrine For Covid-19; First Half Loss Widens

Verona To Trial Ensifentrine For Covid-19; First Half Loss Widens

Read more
14 Aug 2020 07:45

LONDON MARKET PRE-OPEN: easyJet Raises Cash From Aircraft Sale

LONDON MARKET PRE-OPEN: easyJet Raises Cash From Aircraft Sale

Read more
17 Jul 2020 10:49

UK WINNERS & LOSERS SUMMARY: Verona Pharma Rises After Huge Fundraise

UK WINNERS & LOSERS SUMMARY: Verona Pharma Rises After Huge Fundraise

Read more
17 Jul 2020 08:29

Verona Pharma Shares Surge As It Raises USD200 Million For Drug Trial

Verona Pharma Shares Surge As It Raises USD200 Million For Drug Trial

Read more
9 Apr 2020 16:09

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
14 Feb 2020 10:41

UK WINNERS & LOSERS SUMMARY: RBS Plummets As Dividend Lags Consensus

UK WINNERS & LOSERS SUMMARY: RBS Plummets As Dividend Lags Consensus

Read more
3 Feb 2020 14:42

Verona Pharma Changes Top Management With New CEO, Finance Head

Verona Pharma Changes Top Management With New CEO, Finance Head

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.